Detalles de la búsqueda
1.
Risks associated with antiretroviral treatment for human immunodeficiency virus (HIV): qualitative analysis of social media data and health state utility valuation.
Qual Life Res
; 26(7): 1785-1798, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28341926
2.
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.
Lancet
; 385(9987): 2606-15, 2015 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-25890673
3.
Week 144 resistance analysis of elvitegravir/cobicistat/emtricitabine/tenofovir DF versus atazanavir+ritonavir+emtricitabine/tenofovir DF in antiretroviral-naïve patients.
HIV Clin Trials
; 15(5): 218-30, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25350960
4.
Cobicistat-boosted darunavir in HIV-1-infected adults: week 48 results of a Phase IIIb, open-label single-arm trial.
AIDS Res Ther
; 11: 39, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25926858
5.
Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study.
J Acquir Immune Defic Syndr
; 74(2): 180-184, 2017 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27673443
6.
A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults.
J Acquir Immune Defic Syndr
; 74(2): 193-200, 2017 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27753684
7.
Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus.
Antiviral Res
; 125: 63-70, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26640223
8.
Equivalent Decline in Inflammation Markers with Tenofovir Disoproxil Fumarate vs. Tenofovir Alafenamide.
EBioMedicine
; 13: 321-327, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27742226
9.
Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study.
J Acquir Immune Defic Syndr
; 71(5): 530-7, 2016 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26627107
10.
Tenofovir alafenamide vs. tenofovir disoproxil fumarate in single tablet regimens for initial HIV-1 therapy: a randomized phase 2 study.
J Acquir Immune Defic Syndr
; 67(1): 52-8, 2014 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24872136
11.
Phase IIIb, open-label single-arm trial of darunavir/cobicistat (DRV/COBI): Week 48 subgroup analysis of HIV-1-infected treatment-nave adults.
J Int AIDS Soc
; 17(4 Suppl 3): 19772, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25397516
12.
Anti-CD4 monoclonal antibody ibalizumab exhibits breadth and potency against HIV-1, with natural resistance mediated by the loss of a V5 glycan in envelope.
J Acquir Immune Defic Syndr
; 62(1): 1-9, 2013 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23023102
13.
A randomized, double-blind comparison of coformulated elvitegravir/cobicistat/emtricitabine/tenofovir DF vs ritonavir-boosted atazanavir plus coformulated emtricitabine and tenofovir DF for initial treatment of HIV-1 infection: analysis of week 96 results.
J Acquir Immune Defic Syndr
; 62(5): 483-6, 2013 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23337366
14.
Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adults.
J Acquir Immune Defic Syndr
; 63(4): 449-55, 2013 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23807155
15.
A randomized, double-blind comparison of single-tablet regimen elvitegravir/cobicistat/emtricitabine/tenofovir DF vs ritonavir-boosted atazanavir plus emtricitabine/tenofovir DF for initial treatment of HIV-1 infection: analysis of week 144 results.
J Acquir Immune Defic Syndr
; 65(3): e121-4, 2014 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24346640
Resultados
1 -
15
de 15
1
Próxima >
>>